iLite ADCC Target mTNF-alpha Negative Assay Ready Cells Developed and Manufactured by Svar Life Science
The Eagle Biosciences iLite ADCC Target mTNF-alpha (-) Assay Ready Cells are intended for testing:
Content: >250 μL of Assay Ready Cells suspended in cryoprotective medium from Gibco
Receipt and Storage: Upon receipt confirm that adequate dry-ice is present, and the cells are frozen. Immediately transfer to -80°C storage. Cells should be stored at -80°C (do not store at any other temperature) and are stable as supplied until the expiry date shown. Cells should be used within 30 min of thawing.
For Research Use Only
iLite® ADCC Target mTNF-alpha- Assay Ready Cells are based on a human embryonic kidney cell line, HEK293, and have been genetically engineered and optimized to deplete all expression of the surface protein mTNF-alpha. The cells are for use as internal controls together with iLite® ADCC Effector (V) Assay Ready Cells and iLite® ADCC Target mTNF-alpha (+) Assay Ready Cells when measuring the ADCC activity of anti-TNF-alpha antibodies.
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a mechanism whereby pathogenic cells are lysed by lymphocytes, most often Natural Killer (NK) cells. The mechanism involves binding of antibodies to surface antigens on the pathogen. Crosslinking of these antibodies to NK cells through the binding of the Fc-portion to Fc receptors on the NK cells leads to activation of the NK cell and formation of an immune synapse with the pathogenic cell. The NK cell releases cytotoxic granules containing granzymes and perforin into the synapse, leading to apoptosis of the targeted cell (1).
iLite Effector V Assay Ready Cells
iLite ADCC Target mTNF-alpha+
iLite ADCC anti-mTNF-alpha Activity Set
EagleBio在人类中,冠状病毒会引起呼吸道感染。冠状病毒由几种蛋白质组成,包括刺突(S),包膜(E),膜(M)和核衣壳(N)。结果表明,刺突蛋白与血管紧张素转化酶2(ACE2)受体保持足够的亲和力,可将其用作细胞进入的机制。人们主要认为冠状病毒在人与人之间的传播是通过打喷嚏和咳嗽产生的呼吸道飞沫在亲密接触者之间发生的。IgG是响应抗原产生的最丰富的免疫球蛋白,在长期暴露后会保持在体内。Eagle Biosciences仅提供最优质的测定以满足您的需求,并在这些艰难的时期内为您提供最佳的客户服务。